What's in SolasCure Limited's pipeline?

SolasCure Limited has 1 drugs in our index: 0 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with SolasCure Limited's portfolio?

Top competitors by shared drug class: Centre Francois Baclesse, Daryoush Hamidi Alamdari, PhD, Federico II University.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/solascure-limited.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-15 · How we verify

SolasCure Limited — Portfolio Competitive Intelligence Brief

SolasCure Limited pipeline: 0 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Wound healing · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Centre Francois Baclesse · 1 shared drug class
Daryoush Hamidi Alamdari, PhD · 1 shared drug class
Federico II University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for SolasCure Limited:

Cite this brief

Drug Landscape (2026). SolasCure Limited — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/solascure-limited. Accessed 2026-05-15.